---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-030743"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:09:46.173046+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# X4 Pharmaceuticals stockholders elect R. Keith Woods as director, ratify auditor, approve say-on-pay

## Summary
- R. Keith Woods elected with 52.2M for, 29.9M withheld; 53.8M broker non-votes.
- Ratification of PwC as auditor: 128.9M for, 6.6M against, 0.4M abstain.
- Non-binding say-on-pay approved: 67.8M for, 12.2M against, 2.0M abstain, 53.8M broker non-votes.
- All three proposals passed at annual meeting held June 9, 2025.

## SEC filing metadata
- accession: 0001628280-25-030743
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828025030743/0001628280-25-030743-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828025030743/xfor-20250611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-030743
- JSON: https://secwatch.observer/filing/0001628280-25-030743.json
- Plain text: https://secwatch.observer/filing/0001628280-25-030743.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.